The study by Li et al. provides fundamental findings supported by convincing evidence that they defined cellular reprogramming of androgen receptor in neuroendocrine prostate cancer (NEPC). The ...

“Pituitary tumors are the second most common manifestation. Although pancreatic neuroendocrine tumors are less prevalent, they are associated with a higher mortality risk in MEN1 patient ...

The cancer, which develops from the sympathetic nervous system, is the most common type of solid tumor in children outside of the brain. Patients with high-risk neuroblastoma tend to be older than ...

Invikafusp alfa elicited clinically meaningful antitumor activity in patients with advanced solid tumors resistant to anti–PD-1/PD-L1 agents. The select dual T cell agonist invikafusp alfa showed ...

Compared with individuals who did not undergo head/neck CT scans, those that had at least 1 head/neck CT scan were at a significantly higher risk for pediatric brain tumors. Head and neck computed ...

long-acting subcutaneous depot of octreotide under development for the treatment of three chronic and severe disease indications: acromegaly, gastroenteropancreatic neuroendocrine tumors (GEP-NET ...

New data show early hints of the medicine improving patient survival — the gold standard outcome of any cancer study. The drug, ivonescimab, was approved for previously untreated patients with ...

A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, critical role in dampening the immune system's response to cancer.

Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related condition associated with increased mortality among patients with cancer. CHIP mutations with high variant-allele ...